SPC144

Pembrólísúmab

  • Status:
    Veitt
  • Application date:
    18.12.2015
  • Application published:
    15.1.2016
  • Grant published:
    15.10.2019
  • Max expiry date:
    20.1.2031
  • Medicine name:
    Keytruda
  • Medicine for children:
    Yes

Timeline

Today
18.12.2015Application
15.1.2016Publication
15.10.2019Registration
20.1.2031Expires

Marketing license

  • IS authorization number:
    EU/1/15/1024/001
  • Date:
    13.8.2015
  • Foreign authorization number:
    EU/1/15/1024
  • Date:
    21.7.2015

Owner

  • Name:
    Merck Sharp & Dohme B.V.
  • Address:
    Waarderweg 39, BN Haarlem NL

Agent

  • Name:
    Árnason Faktor ehf.
  • Address:
    Guðríðarstíg 2-4, 113 Reykjavík

Patent

Upload documents